6-31366645-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000414224.1(DHFRP2):​n.254A>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.113 in 1,389,596 control chromosomes in the GnomAD database, including 10,985 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.078 ( 630 hom., cov: 32)
Exomes 𝑓: 0.12 ( 10355 hom. )

Consequence

DHFRP2
ENST00000414224.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.831

Publications

14 publications found
Variant links:
Genes affected
DHFRP2 (HGNC:2863): (dihydrofolate reductase pseudogene 2)
HLA-B (HGNC:4932): (major histocompatibility complex, class I, B) HLA-B belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exon 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. Hundreds of HLA-B alleles have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.117 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DHFRP2 n.31366645T>C intragenic_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DHFRP2ENST00000414224.1 linkn.254A>G non_coding_transcript_exon_variant Exon 1 of 1 6
HLA-BENST00000474381.2 linkn.368A>G non_coding_transcript_exon_variant Exon 1 of 9 6
HLA-BENST00000481849.6 linkn.368A>G non_coding_transcript_exon_variant Exon 1 of 8 6

Frequencies

GnomAD3 genomes
AF:
0.0783
AC:
11905
AN:
152122
Hom.:
630
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0371
Gnomad AMI
AF:
0.152
Gnomad AMR
AF:
0.0388
Gnomad ASJ
AF:
0.0458
Gnomad EAS
AF:
0.00480
Gnomad SAS
AF:
0.0616
Gnomad FIN
AF:
0.0860
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.119
Gnomad OTH
AF:
0.0617
GnomAD4 exome
AF:
0.117
AC:
144982
AN:
1237356
Hom.:
10355
Cov.:
24
AF XY:
0.116
AC XY:
72745
AN XY:
626398
show subpopulations
African (AFR)
AF:
0.0361
AC:
1032
AN:
28580
American (AMR)
AF:
0.0300
AC:
1314
AN:
43774
Ashkenazi Jewish (ASJ)
AF:
0.0457
AC:
1119
AN:
24490
East Asian (EAS)
AF:
0.00145
AC:
56
AN:
38632
South Asian (SAS)
AF:
0.0826
AC:
6734
AN:
81494
European-Finnish (FIN)
AF:
0.0877
AC:
4644
AN:
52968
Middle Eastern (MID)
AF:
0.0471
AC:
249
AN:
5290
European-Non Finnish (NFE)
AF:
0.137
AC:
124514
AN:
909424
Other (OTH)
AF:
0.101
AC:
5320
AN:
52704
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
6361
12722
19082
25443
31804
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4198
8396
12594
16792
20990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0782
AC:
11909
AN:
152240
Hom.:
630
Cov.:
32
AF XY:
0.0739
AC XY:
5498
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.0371
AC:
1539
AN:
41534
American (AMR)
AF:
0.0387
AC:
592
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0458
AC:
159
AN:
3472
East Asian (EAS)
AF:
0.00462
AC:
24
AN:
5192
South Asian (SAS)
AF:
0.0627
AC:
303
AN:
4830
European-Finnish (FIN)
AF:
0.0860
AC:
911
AN:
10594
Middle Eastern (MID)
AF:
0.0374
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
0.119
AC:
8103
AN:
68014
Other (OTH)
AF:
0.0611
AC:
129
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
553
1107
1660
2214
2767
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
146
292
438
584
730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.102
Hom.:
740
Bravo
AF:
0.0720
Asia WGS
AF:
0.0220
AC:
77
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
12
DANN
Benign
0.74
PhyloP100
0.83

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2844577; hg19: chr6-31334422; API